NICE Drug allergy: costing statement

"This costing statement considers the cost implications of implementing the recommendations made in Drug allergy: diagnosis and management of drug allergy in adults, children and young people (NICE clinical guideline 183). 1.2 A costing statement of resource effects has been produced for this guideline as variation in clinical practice across the country means users should consider and assess the impact locally."

Costing statement: Drug allergy: diagnosis and management of drug allergy in adults, children 
and young people. Implementing the NICE guideline on Drug allergy in adults, children and young people (CG183)
NICE
September 2014

Read more here.

Using health worker opinions to assess changes in structural components of quality

"Compared to usual care, managed care was significantly associated with better process in terms of diabetes care, fewer secondary care consultations and lower health care costs. The same trends were seen for protocolized care, however they were not statistically significant."

Resource use and costs of type 2 diabetes patients receiving managed or protocolized primary care: a controlled clinical trial
A van der Heijden, et al.
BMC Health Services Research 2014, 14:280

Read more here.